A daily cup of coffee may benefit the heart rather than hurt it, according to new worldwide clinical research that questions long-held medical advice to avoid caffeine in heart rhythm abnormalities. 

The study, which took place at five hospitals throughout the United States, Canada, and Australia, followed 200 patients with persistent atrial fibrillation (AF), a common kind of abnormal heartbeat, as they underwent cardioversion, a surgery meant to restore normal rhythm. Patients were randomly allocated to drink caffeinated coffee every day or to forgo all caffeine-containing goods for six months. 

At the end of the trial period, researchers discovered that those who drank coffee had a considerably lower rate of AF recurrence (47%) than those who abstained (64%). The data indicate that regular coffee consumption was associated with a 39% decreased incidence of recurrent AF. Importantly, no increase in side effects or adverse events was observed among coffee consumers. 

The trial, officially titled Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation and registered as ClinicalTrials.gov Identifier: NCT05121519, took place between November 2021 and December 2024. It presents the first randomised evidence that moderate coffee use may improve heart rhythm stability rather than cause disruptions. 

For decades, doctors have advised patients with heart rhythm disorders to avoid caffeine, believing that it could cause palpitations or irregular beats. However, subsequent research, such as the DECAF (Does Eliminating Coffee Prevent Fibrillation?) experiment, indicates differently. Previous observational research suggested similar patterns but lacked the rigorous design of a clinical trial. 

Atrial fibrillation affects almost 10 million people in the United States alone, and it is becoming more frequent globally. It increases the risk of stroke, heart failure, and other problems; thus, prevention and management are critical public health issues. 

The new data may come as good news to millions of coffee drinkers who rely on their morning cup. Cardiologists, however, emphasise the importance of moderation. One cup per day, as tested in this experiment, appears to be safe and possibly beneficial, although excessive caffeine use can still influence blood pressure and sleep. 

As further research is conducted into caffeine's precise function in cardiac health, the DECAF study has the potential to influence both public perception and therapeutic recommendations for one of the world's most popular beverages – coffee.